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Abstract
Objective To assess the diagnostic performance of quantita-
tive and qualitative image parameters in cone-beam computed
tomography (CBCT) for diagnosis of bisphosphonate-related
osteonecrosis of the jaw (BRONJ).
Materials and methods A BRONJ (22 patients, mean age
70.0 years) group was age and gender matched to a healthy
control group (22 patients, mean age 68.0 years). On CBCT
images two independent readers performed quantitative bone
density value (BDV) measurements with region and volume-
of-interest (ROI and VOI) based approaches and qualitative
scoring of BRONJ-associated necrosis, sclerosis and perios-
teal thickening (1=not present to 5=definitely present).
Intraoperative and clinical findings served as standard of
reference. Interreader agreements and diagnostic performance
were assessed by intraclass correlation coefficients (ICC),
kappa-statistics and receiver-operating characteristic (ROC)
analysis.
Results Twenty-three regions in 22 patients were affected by
BRONJ. ICC values for mean BDVVOI and mean BDV ROI
were 0.864 and 0.968, respectively (p<0.001). The area under
the curve (AUC) for mean BDV VOI and mean BDV ROI
was 0.58/0.83 with a sensitivity of 57/83 % and specificity of
61/77 % for diagnosis of BRONJ, respectively. Kappa values
for presence of necrosis, sclerosis and periosteal thickening
were 0.575, 0.617 and 0.885, respectively. AUC values for
qualitative parameters ranged between 0.90–0.96 with sensi-
tivity of 96 % and specificities between 79–96 % at respective
cutoff scores.
Conclusions BRONJ can be effectively diagnosed with
CBCT. Qualitative image parameters yield a higher diagnostic
performance than quantitative parameters, and ROI-based
attenuation measurements were more accurate than VOI-
based measurements.
Keywords Cone beamCT . Bisphosphonate .
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) .
Diagnostic performance
Introduction
Bisphosphonates are inorganic pyrophosphates effective in
inhibiting bone resorption and have been approved and used
in the past for different indications such as osteoporosis,
Paget’s disease, hypercalcemia related tomalignancy, multiple
myeloma and symptomatic fibrous dysplasia [1–4]. Since
2003, a growing number of reports have been published on
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avascular necrosis of the jaw associated with the use of
bisphosphonates, known as bisphosphonate-related
osteonecrosis of the jaw (BRONJ) [5, 6]. The incidence of
BRONJ is strongly dependent on oral or intravenous applica-
tion and largely varies between 0.0 and 27.5% depending upon
the specific type of bisphosphonate, duration of therapy and the
condition for which bisphosphonates were administered [7]. It
is characterized by exposed bone in the maxillofacial area that
has been present for more than 8 weeks in the setting of prior
bisphosphonate treatment. Prior radiation therapy has to be
excluded [3]. Different hypotheses exist for the pathogenesis
of BRONJ including infection, loss of blood supply, inhibition
of bone turnover and dentoalveolar trauma [8, 9]. Independent
of etiology, early recognition of BRONJ is crucial and seems to
be the best strategy to limit its progression [10].
BRONJ is primarily diagnosed clinically but imaging is
essential for determining the extent of disease, diagnosing early
stages, identifying metastatic disease and excluding fractures
[3, 11]. Different radiological examinations have been applied
in cases of BRONJ but no gold standard has been agreed upon
[12–14]. However, conventional radiography and CT scans are
widely used and may show periosteal reaction, sclerotic lesions
and also mixed bone changes with ill-defined areas of lucency
potentially leading to formations of a sequestrum. In the last
several years cone-beam computed tomography (CBCT) has
been introduced as a diagnostic tool utilizing cone-beam geom-
etry, flat panel detectors and 3D reconstruction algorithms.
Relatively low radiation doses have been reported compared
with conventional CT scans at high isotropic spatial resolution
[15–17]. The recent advances in CBCT techniques and soft-
ware tools for postprocessing have led to its use in surgical
planning especially for head and neck procedures and for
detection and quantification of BRONJ [18].
Diagnosis of BRONJ in CBCT is usually based on classical
subjective image parameters, such as the detection of perios-
teal thickening, sclerosis or bone lucencies, i.e., necrosis [19].
Additionally, changes in bone density lead to changes in x-ray
attenuation that can be quantified by calculating mean bone
density values (BDV) of a certain area or volume. This can
either be measured by 2D regions of interest (ROI) on
multiplanar reformations or 3D volumes of interest (VOI)
generated from a 3D CBCT data set. The latter approach
may potentially facilitate workflow and allow for semiauto-
matic BDV measurements. However, CBCT using flat-panel
detector technology is known to be susceptible to certain gray-
level inconsistencies, i.e., variation of x-ray attenuation [20].
Hence, adequate VOIs and cutoff attenuation values may be
influenced by these inconsistencies but have to be applied in
order to reliably detect BRONJ.
The purpose of this study was to assess the diagnostic per-
formance and consistency of quantitative and qualitative image
parameters used in CBCT for the diagnosis of BRONJ with
clinical and intraoperative findings as standard of reference.
Materials and methods
Due to the retrospective nature of this study, ethical board
approval was not required by local laws and regulations, and
the informed consent requirement was waived by the depart-
ments where the study was carried out. The study was per-
formed according to the guidelines of the Declaration of
Helsinki concerning Ethical Principles for Medical Research
Involving Human subjects.
Patients
Twenty-two patients (17 females, 5 males, mean age
70.0 years; age range 46–85 years) with BRONJ were retro-
spectively included between January 2011 and December
2013. Inclusion criteria were overt BRONJ (Fig. 1) diagnosed
by a maxillofacial surgeon (XX) with 10 years of professional
experience based on generally accepted diagnostic criteria of
the American Association of Oral and Maxillofacial Surgeons
(AAOMS) [21–23], i.e., exposed bone in the maxillofacial
area that has been present for more than 8 weeks in the setting
of prior bisphosphonate treatment. Radiation therapy had to be
excluded by definition. Other exclusions included any signs of
soft tissue infection (swelling, abscess formation) and/or hard
tissue infection (osteolysis of spongiotic bone with irregular
margins) within the maxilla or mandible. Final exclusions
included invasive sinusitis, periapical lesions due to pulpal
infection resulting in osteomyelitis and bone tumors of the jaw
(primary or metastatic). BRONJ group individuals were re-
ferred to the Department of Cranio-Maxillofacial Surgery for
clinical and radiological evaluation prior to possible scheduled
surgery and had histories of bisphosphonate intake due to
osteoporosis (n=7), osseous metastasis and malignancy (n=
15) (Table 1). Although BRONJ could not be definitely dis-
tinguished from possible metastatic disease by imaging alone,
necrotic foci in BRONJ are often associated with bone lysis
and fragmentation on the background of bone sclerosis, a
finding that is rather rare in bone metastases. Also clinical
history with prior bisphosphonate treatment for a substantial
amount of time (mean 33.1 months, range 8–120 months) was
Fig. 1 A 65-year-old male patient with clinically overt BRONJ and
extensive areas of necrosis and exposed bone in the left mandible
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highly suggestive of BRONJ. Definite diagnosis was
established by one and/or multiple biopsies obtained by direct
surgical excision and subsequent histopathologic analysis.
Both clinical and radiological evaluations were used to iden-
tify, guide and obtain the target tissue.
An age- and gender-matched healthy control group (be-
tween January 2012 and December 2013) included 22 indi-
viduals (mean age 68.0 years, age range 45–83 years) whose
personal records and CBCT imaging reports revealed no bone
pathology of their jaws.
CBCT
All study subjects underwent imaging using the standard
clinical cone beam system and standard imaging parameters
as established at the authors departments. The following sys-
tem was used: a KaVo 3-D eXam (KaVo Dental GmBH,
Biberach, Germany) CBCT unit with an amorphous silicon
flat-panel detector (20×25 cm). Imaging parameters were as
follows: The exposure volumewas uniformly set at a height of
102 mm. The size of the minimal isotropic voxel was 0.4 mm.
The scan was set at a high-frequency constant potential of 120
kVp. The occlusal plane of each patient was set parallel to the
floor base using ear rods and a chin rest, and patient position
was adjusted according to alignment laser beams. All scans
were performed by a uniquely trained team of experienced
dento-maxillofacial radiographers. According to the manufac-
turer’s instructions, the CBCT unit and its software were
regularly calibrated using normalized phantom material rec-
ommended by the manufacturer.
Acquired 3D data were reconstructed at a transaxial slice
thickness of 0.4 mm and transferred to an independent work-
station (GE Healthcare, Advantage Workstation, AW 4.2)
where postprocessing and readout were performed by two
independent readers who were blinded to each other and
patient data (one radiologist with 4 years of experience in
head-and-neck imaging and one surgeon with 5 years of
experience in maxillofacial surgery).
Postprocessing and readouts
In a first postprocessing step, volume rendering of the trans-
ferred images was performed. In order to exclude soft tissue
but include high density/bone material, only lower and upper
threshold attenuation values of voxels were set at 200 and
3,071 HU. Then, the mandible was neatly segmented out of
Table 1 Demographics of patients with BRONJ
Gender Age
(years)
Disease Bisphosphonate Duration of treatment
before BRONJ (months)
History of trauma
F 85 Breast cancer Zoledronate 48 Tooth extraction
F 57 Breast cancer Zoledronate 48 –
F 77 Breast cancer Zoledronate 8 Tooth extraction
F 80 Breast cancer Zoledronate 9 Tooth extraction
F 69 Breast cancer Zoledronate 22 Explantation
F 67 Osteoporosis Zoledronate Tooth extraction
F 67 Breast cancer Zoledronate 34 –
M 71 Breast cancer Denosumab 24 Tooth extraction
M 67 Renal cell cancer Zoledronate Explantation
F 67 Osteoporosis Alendronate 36 Tooth extraction
F 75 Osteoporosis Alendronate 120 Tooth extraction
F 64 Breast cancer Zoledronate 9 Tooth extraction
F 83 Osteoporosis Ibandronate 12 Poorly fitting denture
F 46 Melanoma Zoledronate –
F 79 Osteoporosis Ibandronate 18 Tooth extraction
F 61 Malignant mesothelioma Zoledronate 18 Tooth extraction
F 75 Osteoporosis Alendronate 36 –
M 70 Multiple myeloma Zoledronate Implantation
M 65 Lung cancer Zoledronate 36 –
F 60 Breast cancer Zoledronate Tooth extraction
M 79 Prostate cancer Zoledronate 48 –
F 75 Osteoporosis Pamidronate 36 Tooth extraction
– No trauma in history
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the total volume-rendered scan and each mandible divided into
ten different regions (i.e., VOIs) with characteristic anatomic
boundaries: condylar process (head and neck), coronoid pro-
cess, ascending ramus, posterior mandible and anterior man-
dible (Fig. 2). Teeth were carefully cropped from the whole
mandible and thus not considered for subsequent analysis.
Quantitative analysis
Based on the attenuation value of each voxel, mean bone
attenuation, i.e., density values in HU,wasmeasured by placing
equally sized ROIs (10 mm2) in the center of each segmented
mandibular region on axial images of each mandible. Care was
taken to include spongiotic bone only and to exclude cortical
bone (Fig. 3). The mean BDVs of each segmented VOI and the
entire volume of each mandible were recorded.
Qualitative analysis
Transaxial plane views of the mandible were used for qualitative
analysis. Two independent readers visually scored each mandib-
ular region for the presence of BRONJ according to three differ-
ent parameters: necrosis with lucency, sclerosis and periosteal
thickening. Each parameter was graded on a 5-point Likert scale
(1=not present, 2=probably present, 3=slightly present, 4=
moderately present and 5=markedly present) (Fig. 4).
Statistical analysis
All statistical analysis was performed using SPSS version 19.0
(SPSS, IBM Corp., NY, NY, USA). For quantitative evalua-
tion the interreader agreement was assessed by calculating
intraclass correlation coefficients (ICCs). Interreader agree-
ment for qualitative parameters was assessed by calculating
kappa values. According to Landis and Koch [24], ICC and
kappa values were interpreted as follows: <0 as poor, 0–0.2 as
slight, 0.21–0.4 as fair, 0.41–0.60 as moderate, 0.61–0.80 as
substantial and values between 0.81 and 1 as almost perfect
agreement . Quantitative and qualitative data were also ana-
lyzed with receiver-operating characteristic (ROC) analysis,
and the area under ROC curve was employed as an estimate of
the diagnostic performance. From optimal cutoff values re-
spective sensitivities and specificities were calculated. Un-
paired Student’s t-tests were used to compare mean BDVs of
mandibular bone between different groups. Spearman rank
test was used to analyze correlation between the BDVs and
anatomic region of healthy mandibles. A p-value of 0.05 was
considered statistically significant.
Results
All intraoperatively taken specimens showed distinct histo-
pathological features of BRONJ. In total 23 regions (100 %)
Fig. 2 Whole mandible (left) and right hemimandible (right). The man-
dible was neatly segmented out of the total volume-rendered scan volume
and divided into ten different regions: right hemimandible: condylar
process=region 1, coronoid process=region 2, ramus=region 3, posterior
mandible=region 4, anterior mandible=region 5, left hemimandible:
condylar process=region 6, coronoid process=region 7, ramus=region
8, posterior mandible=region 9, anterior mandible=region 10. Note: the
alveolar process including teeth was carefully cropped from the whole
mandible and not considered for ensuing analysis
Fig. 3 Equally sized ROIs (10 mm²) were placed in the center of each
mandibular region on axial images. ROIs 4 and 9 indicate posterior
mandible, 5 and 10 indicate anterior mandible regions. Care was taken
to include spongiotic bone only and to exclude cortical bone. Note BRONJ
with increased bone density in the left posterior mandible (region 9)
1672 Skeletal Radiol (2014) 43:1669–1678
were affected by BRONJ: 7 cases in region 4 (30 %), 2 cases
in region 5 (9 %), 12 cases in region 9 (52 %) and 2 cases in
region 10 (9 %) of the mandible. Consecutively, four cases
were in the anterior mandible (18 %), while the majority of
total lesions (19 lesions, 82 %) were localized in the posterior
mandible.
Quantitative analysis
Descriptive data of the quantitative mean BDV VOI and ROI
of affected (BRONJ) and nonaffected regions of the mandible
are presented in Table 2. An illustration of the distribution
among the ten different regions is provided by box plots
(Fig. 5).
Overall interreader agreements for mean BDV VOI and
mean BDV ROI were “almost perfect.” Corresponding ICCs
were 0.864 and 0.948, respectively (all p<0.001). Mean BDV
VOIs of whole mandibles were not significantly different
between the BRONJ and control group (p=0.099).
An increase in the mean bone density value from the
condylar process (head/neck) to the anterior hemimandible
in healthy individuals was found [484 to 992 (Δ508) HU for
BDV VOI and 206 to 834 (Δ628) HU for BDV ROI].
Spearman correlation coefficients for mean BDV VOI with
region number were 0.89 (p<0.001) and for mean BDV ROI
Fig. 4 a BRONJ with sclerosis (asterisk) and periosteal thickening
(arrows) in the left anterior and posterior mandible of a 70-year-old male
patient with multiple myeloma receiving zoledronate for an uncertain
period of time. Sclerosis and periosteal thickening were rated 3 (slightly
present) and 4 (moderately present) on the 5-point Likert scale,
respectively. b and c BRONJ in the left anterior mandible of a 65-year-
old man with lung cancer receiving zoledronate for 36 months with
marked bone necrosis (arrowheads), periosteal thickening (arrows) and
adjacent sclerosis (asterisk). Findings were all rated 5 (markedly present)
on the 5-point Likert scale
Table 2 Descriptive data of mean bone density values (BDV) in Hounsfield units (HU) of affected (BRONJ) and nonaffected mandibular regions
VOI ROI
Mandibular
region
Number of mandibles
affected (n)
Mean BDV VOI
nonaffected (± SD)
Mean BDV VOI
affected (± SD)
P value Mean BDV ROI
nonaffected (± SD)
Mean BDV ROI
affected (± SD)
P value
1 – 480.4 (±49.0) 202.2 (±116.4)
2 – 710.1 (±77.2) 881.9 (±03.1)
3 – 724.1 (±83.3) 541.5 (±206.7)
4 7 855.6 (±76.6) 946.1 (±63.3) 0.005 669.9 (±181.9) 1,044.3 (±136.7) 0.001
5 2 1,002.4 (±96.5) 982.0 (±101.8) 0.772 840.3(±211.4) 1,165.0 (±195.2) 0.039
6 – 488.0 (±62.6) 209.7 (±131.2)
7 – 725.2 (±82.3) 885.6 (±202.1)
8 – 737.3 (±96.2) 550.8 (±257.2)
9 12 853.2 (±72.9) 934.1 (±119.8) 0.009 631.2 (±175.1) 985.7 (±240.7) 0.001
10 2 981.7 (±108.2) 1,063.0 (±8.5) 0.299 828.2 (±213.2) 1,139.0 (±231.9) 0.051
Regions: right hemibandible: condylar process=region 1, coronoid process=region 2, ramus=region 3, posterior mandible=region 4, anterior
mandible=region 5; left hemibandible: condylar process=region 6, coronoid process=region 7, ramus=region 8, posterior mandible=region 9, anterior
mandible=region 10. Note: data of whole mandibles (region 11) showed no significant differences between affected and nonaffected jaws but are not
depicted in this table in order to keep with consistent region numbering from 1 to 10
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0.48 (p<0.001), and if regions 2 and 7 (=coronoid process)
were excluded, the correlation coefficient for mean BDV
VOI was 0.92 (p<0.001) and for mean BDV ROI 0.79
(p<0.001).
ROC Analysis
The area under the curve (AUC) for mean BDV VOI and
mean BDV ROI was 0.58 and 0.83, respectively. Using a
cutoff BDV of 947 and 910 HU, a sensitivity of 57 and
83 % with a specificity of 61 and 77 % was calculated,
respectively (Fig. 6 and Table 3).
If the analysis was restricted only to posterior mandible
regions (regions 4 and 9) where 82 % of the total lesions were
located, the AUC values for mean BDV VOI and mean BDV
ROI were 0.76 and 0.9, respectively. Using a cutoff BDV of
874 and 798 HU, a sensitivity of 84 % with a specificity of 64
and 75 % was calculated, respectively.
Fig. 5 Box plot diagram shows the mean BDV VOI a and mean BDV
ROI b distribution for BRONJ-affected and -nonaffected regions of the
mandible. Right hemimandible: condylar process=region 1, coronoid
process=region 2, ramus=region 3, posterior mandible=region 4,
anterior mandible=region 5, left hemimandible: condylar process=region
6, coronoid process=region 7, ramus=region 8, posterior mandible=
region 9, anterior mandible=region 10. Asterisks mark statistical signif-
icance: * <0.05, **<0.01, ***<0.001
Fig. 6 Receiver-operating characteristic (ROC) curves for mean BDVVOI and mean BDVROI a and for necrosis, sclerosis and periosteal thickening b
considering clinical and intraoperative findings as standard of reference for the presence of BRONJ
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Qualitative analysis
The frequencies of the qualitative parameters for BRONJ-
affected regions are presented in Table 4. The mean score for
the three qualitative parameters (necrosis, sclerosis and perios-
teal thickening) were 4.61 (SD±0.89), 4.74 (SD±0.86) and 4.39
(SD±0.99); 17 (74 %) out of 23 BRONJ foci showed osteolytic
changes/necrosis, and periostal thickening was seen in 14
(61 %) foci. There was moderate to almost perfect interreader
agreement for presence of necrosis, sclerosis and periosteal
thickening (kappa values: 0.575, 0.617 and 0.885, respectively).
ROC Analysis
AUC values from ROC analysis for qualitative parameters
were 0.96 for necrosis, a cutoff score of 3.50 resulting in
sensitivity of 96 % and specificity of 96 %; 0.90 for sclerosis,
a cutoff score of 3.50 resulting in sensitivity of 96 % and
specificity of 79 %; 0.93 for periosteal thickening, a cutoff
score of 2.50 resulting in sensitivity of 96 % and specificity of
86 %. Thus, high accuracies were obtained for all qualitative
parameters (Fig. 6 and Table 3).
If the analysis was restricted only to posterior mandible
regions (regions 4 and 9) where 82 % of the total lesions were
located, AUC values from ROC analysis for qualitative pa-
rameters were 0.96 for necrosis, a cutoff score of 2.5 resulting
in sensitivity of 95 % and specificity of 100 %; 0.96 for
sclerosis, a cutoff score of 3.5 resulting in sensitivity of
100 % and specificity of 88 %; 0.95 for periosteal thickening,
a cutoff score of 2.50 resulting in sensitivity of 95 % and
specificity of 91 %.
Discussion
Several reports have evaluated the appearance of BRONJ in
different imaging modalities. Radiography is usually consid-
ered as first-line, while CT and MRI as second-line imaging
modalities. MRI may not only help to determine the number
and extension of foci, including soft tissue involvement, but
also allow for early disease detection [25]. However, major
issues were discovered when research studies were performed
comparing radiography, CT, MRI, scintigraphy, SPECT-CT
and positron emission tomography. Several studies revealed
substantial differences in interpretation of disease extent based
Table 3 ROC analysis for quantitative (mean bone density values, mean BDV) and qualitative image parameters (necrosis, sclerosis and periosteal
thickening) of BRONJ-affected mandibular regions
Quantitative Qualitative
Mean BDV VOI Mean BDV ROI Necrosis Sclerosis Periosteal thickening
Anterior and posterior mandible (regions 4, 5, 9 and 10)
AUC 0.58 0.83 0.96 0.90 0.93
95 % CI (0.46; 0.70) (0.74; 0.92) (0.91; 1.00) (0.84; 0.96) (0.87; 0.99)
Cutoff 946.50 909.50 3.50 3.50 2.50
Sensitivity 57 % 83 % 96 % 96 % 96 %
Specificity 61 % 77 % 96 % 79 % 86 %
Posterior mandible (regions 4 and 9)
AUC 0.76 0.90 0.97 0.96 0.95
95 % CI (0.62; 0.90) (0.81; 0.99) (0.92; 1.00) (0.92; 0.99) (0.88; 1.00)
Cutoff 874 798 2.50 3.50 2.50
Sensitivity 84 % 84 % 95 % 100 % 95 %
Specificity 64 % 75 % 100 % 88 % 91 %
Regions: right hemibandible: condylar process=region 1, coronoid process=region 2, ramus=region 3, posterior mandible=region 4, anterior
mandible=region 5; left hemibandible: condylar process=region 6, coronoid process=region 7, ramus=region 8, posterior mandible=region 9, anterior
mandible=region 10
Table 4 Frequencies of scores of qualitative parameters for BRONJ-
affected anterior and posterior mandible regions
Necrosis Sclerosis Periosteal thickening
Score Frequency
(Percentage of total)
Frequency
(Percentage of total)
Frequency
(Percentage of total)
1 1 (4.3) 1 (4.3) 1 (4.3)
2
3 2 (8.7)
4 5 (21.7) 2 (8.7) 6 (26.1)
5 17 (73.9) 20 (87.0) 14 (60.9)
Scores:1=not present, 2=probably present, 3=slightly present, 4=mod-
erately present and 5=markedly present
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upon the imaging modality used [12–14]. These variances
hindered clear-cut definition of disease borders and straight-
forward therapy planning. As CBCT has gained increasing
attention in recent years because of the presumably reduced
radiation dose when compared to standard multidetector CT, it
has become more important to assess its diagnostic perfor-
mance in the detection and quantification of BRONJ, espe-
cially when surgical therapy is planned. In a recent study,
Cankaya et al. found attenuation measurements in CBCT
using Hounsfield units (HU) to be efficient in the diagnosis
of BRONJ [1], corroborating the current notion of bone den-
sity changes in the evolution of BRONJ. We could show that
quantitative BDV assessments are reliable procedures with
high interreader agreement, based on either ROI or VOI
measurements (ICC values for mean BDV VOI and mean
BDV ROI of 0.864 and 0.968, p<0.001), reflecting rather
high reproducibility independent of reader experience. We
have however found different performances for both
postprocessing algorithms. ROI-based measurements resulted
in a higher AUC than VOI-based measurements. Consecu-
tively, sensitivity/specificity at the respective cutoff BDVs
amounted to only 57/61 % in VOI- as opposed to 83/77 %
in ROI-based BDVmeasurements. This unexpected moderate
performance of VOI-based measurements might be partly due
to the specific segmentation process during postprocessing.
Although it was a semiautomatic step performed in a stan-
dardized way by both readers blinded to the presence or
absence of BRONJ, the region borders had to be chosen
according to each reader’s judgement. This was based on what
they thought would cover the affected bone areas and on what
the typical anatomic region borders of the mandible were. On
the other hand, ROIs were simply placed in the center of each
region excluding cortical bone. However, if a region was
affected by BRONJ with concomittant locally altered anato-
my, volume loss or density changes in the centrally positioned
ROI could have been inadvertently placed in the peripheral,
mostly sclerotic area of a BRONJ. Thus, BDVs of ROIs in
BRONJ-affected regions were likely higher than in standard-
ized VOI segmentations. Additionally, although much care
was taken to crop teeth, including radices, minimal radicular
remnants may have slightly increased the mean BDVs of
VOIs, thereby reducing discrimination of healthy from path-
ologic conditions.
Interestingly, no difference was seen between the mean
BDVof whole mandibles between healthy and diseased indi-
viduals (p=0.099). The overall bone density changes might be
too small to detect when looking at whole mandibles. How-
ever, in healthy individuals an interesting increase of mean
BDV was seen from the condylar process toward the anterior
hemimandible in both ROI and VOI algorithms. This correla-
tion was even more pronounced when the very thin and
mostly sclerotic coronoid process was excluded from the
analysis. To the authors’ knowledge, this has not been
described before. Mean bone density reflects adaptive reac-
tions to biomechanic forces [26]. Regions with increased
BDV may therefore be exposed to increased masticatory
forces, as is the case in the mandibular body. This finding is
important as different cutoff BDVs for discrimination of
physiologic from pathologic conditions apply to different
regions of the mandible. The cutoff BDVs for ROI and VOI
based measurements presented herein apply to the anterior
and/or posterior mandibular body only, as only these regions
were affected by BRONJ in our study population. Eighty-two
percent of total lesions in our study population were localized
in the posterior mandible regions. When focusing only on
these cases, respective AUCs from ROC analyses increased
considerably with improved sensitivity and specificity for
both VOI- and ROI-based approaches. We acknowledge the
fact that respective cutoff attenuation values may perform best
when applied in these specific situations. However, diagnostic
performance is also rather good when dealing with BRONJ in
the combined anterior and posterior mandible, i.e., the entire
mandibular body. In the authors’ experience, other parts of the
mandible may rarely be affected with BRONJ, and attenuation
changes may not occur or be easily detected, e.g., the coronoid
process.
Surprisingly, qualitative analysis scores for necrosis, scle-
rosis and periosteal thickening showed a higher diagnostic
performance than quantitative BDV measurements. AUCs
with sensitivity and specificity were high for all criteria, with
the highest values seen for necrosis and periosteal thickening.
This finding supports the personal experience of the authors
and other reports [1, 3] that early and mostly subtle changes in
BRONJ often begin with periosteal thickening prior to evolv-
ing into overt sclerotic foci. On the other hand, focal osteolytic
changes reflect bone degradation specific to advanced stages
of osteonecrosis. Seventeen (74 %) out of 23 BRONJ foci
showed osteolytic changes/necrosis, and periosteal thickening
was seen in 14 (61 %) foci. Sclerosis at different degrees was
also common. These scores seem to reflect rather advanced
stages of BRONJ in our study population. Although
interreader agreements for qualitative analysis were moderate
to almost perfect, they were somewhat inferior to the quanti-
tative results. In our study population there was a high inci-
dence of third generation bisphosphonates, i.e., highly potent,
nitrogen-containing compounds with anti-bone resorptive and
-angiogenic effects, which have been associated with higher
incidences of BRONJ [27]. However, age is an independent
risk factor for development of BRONJ, and the mean patient
age of the study population was 70 years, i.e., rather high. In
addition, prior to diagnosis most of the patients had undergone
surgical procedures such as tooth extraction. This traumatiza-
tion of the jaw bone may additionally have triggered and
increased the incidence of BRONJ with development of ad-
vanced stages. Hence, the diagnostic performance of CBCT in
early stages unfortunately cannot be inferred from our data.
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Early stages of BRONJ are associated with nonspecific clin-
ical symptoms, and imaging is often delayed or may be
nondiagnostic. CBCT may be able to detect early changes,
e.g., periosteal thickening or bone density changes, before
overt necrotic bone is seen on visual inspection. This however
should be the focus of future studies, as earlier detection may
lead to more efficient therapy.
We acknowledge certain limitations to this study. First, a
rather small sample size of 22 patients with BRONJ was
analyzed. The study was retrospective, and control subjects
were included nonconsecutively. In addition, BRONJ foci
were mostly found in the posterior mandible (82 %). Further
studies with larger cohorts and varied BRONJ locations are
required. Second, each group (healthy vs. BRONJ) consisted
of 17 female and only 5 male individuals, leading to a female
majority. Therefore, subtle gender-specific differences cannot
be ruled out with certainty. Third, CBCT bone density mea-
surements do not yield equally robust bone density measure-
ments as compared to quantitative multidetector CT (q-CT),
for example. However, the CBCT system used in this study to
image all patients is regularly calibrated, and identical patient
positioning and reconstruction algorithms assure comparable
imaging data.
Conclusion
BRONJ can effectively and reliably be diagnosed and quan-
tified with CBCT. Qualitative image parameters yield a higher
diagnostic performance than quantitative bone density values,
among which ROI-based attenuation measurements were
more accurate than VOI-based measurements. Future studies
should focus on the potential of CBCT to detect early, clini-
cally not fully overt BRONJ.
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